Serous ovarian borderline tumors: modern classification and biology


如何引用文章

全文:

详细

In this article there are considered current views on biology of ovarian serous borderline tumors, there is presented a modern histological classification of 2014, which has undergone some changes. Variants of serous borderline tumors are described in terms of morphology, clinical course and prognosis. Also there is discussed the issue of the pathogenesis in the development of ovarian borderline tumors, the contribution of gene mutations in the occurrence of borderline, poorly or well differentiated ovarian tumors. There are described in details features of morphology of serous borderline tumors, the interrelationship of their occurrence and dedifferentiation in dependence on the molecular and genetic deteriorations. In the article there is considered the microinvasive version of the serous borderline tumors and specified criteria for the establishment of this diagnosis. There are given the definition and characterization of micropapillary serous borderline tumors, there is discussed their impact on the course of the disease and prognosis. The issue of terminology is considered in terms of current views and history.

作者简介

Irina Davydova

N.N. Blokhin Russian Cancer Research Center

Email: davydova06@mail.ru
MD, PhD, senior researcher of the Gynecological Department of the Research Institute of Clinical Oncology Moscow, 115478, Russian Federation

V. Kuznetsov

N.N. Blokhin Russian Cancer Research Center

Moscow, 115478, Russian Federation

A. Karseladze

N.N. Blokhin Russian Cancer Research Center

Moscow, 115478, Russian Federation

L. Meshcheryakova

N.N. Blokhin Russian Cancer Research Center

Moscow, 115478, Russian Federation

参考

  1. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am. J. Clin. Pathol. 2005; 123 (Suppl.): 13-57.
  2. Taylor H.C. Jr. Malignant and semi malignant tumours of the ovary. Surg. Gynecol. 1929; 48: 204-30.
  3. Silverberg S. Borderline ovarian tumors: consensus, controversy, and continuing challenges. Pathol. Case Rev. 2006; 11: 9-17.
  4. Bast R.C. Jr., Hennessy B., Mills G.B. The biology of ovarian cancer: new opportunities for translation. Nat. Rev.Cancer. 2009; 9: 415-28.
  5. Cadron I., Leunen K., Van Gorp T., Amant F., Neven P., Vergote I. Management of borderline ovarian neoplasms. J. Clin. Oncol. 2007; 25: 2928-37.
  6. deSouza N.M., O’Neill R., McIndoe G.A., Dina R., Soutter W.P. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. Am. J. Roentgenol. 2005; 184: 999-1003.
  7. Gershenson D.M. Clinical management potential tumours of low malignancy. Best Pract. Res. Clin. Obstetr. Gynaecol. 2002; 16: 513-27.
  8. Swanton A., Bankhead C.R., Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur. J. Obstetr. Gynecol. Reprod. Biol. 2007; 135: 3-7.
  9. Gotlieb W.H., Chetrit A., Menczer J., Hirsh-Yechezkel G., Lubin F., Friedman E. et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol. Oncol. 2005; 97: 780-3.
  10. Webb P.M., Purdie D.M., Grover S., Jordan S., Dick M.L., Green A.C. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol. Oncol. 2004; 92: 232-9.
  11. Kurman R.J., Сarcanqiu M.L., Herrington C.S., Young R.H. WHO Classification of Tumours of Female Reproductive Organs. 4-th Ed. - Lyon: IARS; 2014.
  12. Tavassoli F.A., Devilee P. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
  13. Jones M.B. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin. Obstetr. Gynecol. 2006; 49: 517-25.
  14. Kurman R.J., Shih Ie.M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int. J. Gynecol. Pathol. 2008; 27: 151-60.
  15. Shih Ie.M, Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 2004; 164: 1511-8.
  16. Shih Ie.M., Kurman R.J. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin. Cancer Res. 2005; 11: 7273-9.
  17. Sieben N.L., Oosting J., Flanagan A.M., Prat J., Roemen G.M., Kolkman-Uljee S.M. et al. Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. J. Clin. Oncol. 2005; 23: 7257-64.
  18. Bell D.A., Scully R.E. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum. Pathol. 1990; 21: 397-403.
  19. Fadare O. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). Int. J. Gynecol. Cancer. 2009; 19: 103-8.
  20. Seidman J.D., Kurman R.J. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum. Pathol. 2000; 31: 539-57.
  21. Longacre T.A., Kempson R.L., Hendrickson M.R. Well-differentiated serous neoplasms of the ovary. Pathology (Philad.). 1993; 1(2): 255-306.
  22. Leitao M.M. Jr., Boyd J., Hummer A., Olvera N., Arroyo C.D., Venkatraman E. et al Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. Am. J. Surg. Pathol. 2004; 28(2): 147-59.
  23. Hogg R., Scurry J., Kim S.N., Friedlander M., Hacker N. Microinvasion links ovarian serous borderline tumor and grade 1 invasivecarcinoma. Gynecol. Oncol. 2007; 106(1): 44-51.
  24. Morice P., Camatte S., Rey A., Atallah D., Lhommé C., Pautier P. et al. Prognostic factors for patients with advanced stage serous borderline tumours ofthe ovary. Ann. Oncol. 2003; 14(4): 592-8.
  25. Silva E.G., Gershenson D.M., Malpica A., Deavers M. The recurrence and the overall survival rates of ovarian serous borderlineneoplasms with noninvasive implants is time dependent. Am. J. Surg. Pathol. 2006; 30(11): 1367-71.
  26. Katzenstein A.L., Mazur M.T., Morgan T.E., Kao M. Proliferative serous tumors of the ovary. Histologic features and prognosis. Am. J. Surg. Pathol. 1978; 2(4): 339-55.
  27. McKenney J.K., Balzer B.L., Longacre T.A. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am. J. Surg. Pathol. 2006; 30(10): 1209-21.
  28. Mooney J., Silva E., Tornos C., Gershenson D. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol. Oncol. 1997; 65(1): 30-5.
  29. Kempson R.L., Hendrickson M.R. Ovarian serous borderline tumors: the citadel defended. Hum. Pathol. 2000; 31(5): 525-6.
  30. Scully R.E., Young R., Clement P.B. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligament. In: Atlas of Tumor Pathology. 3rd Series. Washington DC: Arm Forces Institute of Pathology; 1998: Fascicle 23.
  31. Silva E.G., Kurman R.J., Russell P., Scully R.E. Symposium: ovarian tumors of borderline malignancy. Int. J. Gynecol. Pathol. 1996; 15(4): 281-302.
  32. Longacre T.A., McKenney J.K., Tazelaar H.D., Kempson R.L., Hendrickson M.R. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am. J. Surg. Pathol. 2005; 29(6): 707-23.
  33. Prat J., De Nictolis M. Serous borderline tumors of the ovary: a longterm follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am. J. Surg. Pathol. 2002; 26(9): 1111-28.
  34. Sangoi A., McKenney J.K., Dadras S.S., Longacre T.A. Lymphatic Vascyular Invaqsion in Ovarian Serous Tumors of Low Malignant Potential with Stromal Microinvasion. A case Study. Am. J. Surg. Pathol. 2008; 32(2): 261-8.
  35. Russell P. The pathological assessment of ovarian neoplasms. II: The proliferating ‘epithelial’ tumours. Pathology. 1979; 11(2): 251-82.
  36. Serov S.F., Scully S.R., Sobin L.H. Histologic Typing of Ovarian Tumors. Geneva: World Health Organization; 1973.
  37. Diaz-Padilla I., Malpica A.L., Minig L., Chiva L.M., Gershenson D.M., Gonzalez-Martin A. Ovarian low-grade serous carcinoma: a comprehensive update. Gynecol. Oncol. 2012; 126(2): 279-85.
  38. Burks R.T., Sherman M.E., Kurman R.J. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am. J. Surg. Pathol. 1996; 20(11): 1319-30.
  39. Singer G., Stöhr R., Cope L., Dehari R., Hartmann A., Cao D.F. et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am. J. Surg. Pathol. 2005; 29(2): 218-24.
  40. Boyd C., McCluggage W.G. Low-grade ovarian serous neoplasms (Low-grade serous carcinoma and serous borderline tumor) associated with high grade serous or undifferentiated carcinoma: Report of a series of cases of an unusual phenomenon. Am. J. Surg. Pathol. 2012; 36(3): 368-75.
  41. May T., Virtanen C., Sharma M., Milea A., Begley H., Rosen B., Murphy K.J. Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary. Gynecol. Oncol. 2010; 117(1): 9-17.
  42. O’Neill C.J., Deavers M.T., Malpica A. et al. An immunohistochemical comparison between low-grade and high-grade ovarian serous. Am. J. Surg. Pathol. 2005; 29(8):1034-41.

版权所有 © Eco-Vector, 2016


 


##common.cookie##